RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer
2015 · Nature Communications · 619 citations
https://doi.org/10.1038/ncomms7377
J
John T. Poirier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
415
Papers
16.6K
Citations
58
h-index
96
i10-index
John T. Poirier is an academic researcher from NYU Langone Health. The author has contributed to research in topics: Lung Cancer Research Studies & Lung Cancer Treatments and Mutations & Radiopharmaceutical Chemistry and Applications. The author has an h-index of 58, co-authored 353 publications.
ORCID: 0000-0001-9795-5644Papers by this author
worksChemosensitive Relapse in Small Cell Lung Cancer Proceeds through an EZH2-SLFN11 Axis
2017 · Cancer Cell · 526 citations
https://doi.org/10.1016/j.ccell.2017.01.006
Unravelling the biology of SCLC: implications for therapy
2017 · Nature Reviews Clinical Oncology · 477 citations
https://doi.org/10.1038/nrclinonc.2017.71
SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization
2020 · Journal of Thoracic Oncology · 476 citations
https://doi.org/10.1016/j.jtho.2020.09.009
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
2021 · Cancer Cell · 408 citations
https://doi.org/10.1016/j.ccell.2021.09.008
HER2-Mediated Internalization of Cytotoxic Agents in <i>ERBB2</i> Amplified or Mutant Lung Cancers
2020 · Cancer Discovery · 279 citations
https://doi.org/10.1158/2159-8290.cd-20-0215
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat